In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The price of Alnylam Pharmaceuticals Inc (NASDAQ: ALNY) closed at $277.16 in the last session, up 1.16% from day before closing price of $273.99. In other words, the price has increased by $1.16 from its previous closing price. On the day, 0.56 million shares were traded. ALNY stock price reached its highest trading level at $279.36 during the session, while it also had its lowest trading level at $269.0.
Ratios:
We take a closer look at ALNY’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 12.86 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 2225.92. For the most recent quarter (mrq), Quick Ratio is recorded 2.69 and its Current Ratio is at 2.75. In the meantime, Its Debt-to-Equity ratio is 84.27 whereas as Long-Term Debt/Eq ratio is at 80.17.
Goldman Upgraded its Neutral to Buy on August 16, 2024, whereas the target price for the stock was revised from $198 to $370.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 27 ’25 when Garg Pushkal sold 52,592 shares for $285.00 per share. The transaction valued at 14,988,720 led to the insider holds 11,989 shares of the business.
Garg Pushkal bought 52,592 shares of ALNY for $14,988,720 on Jan 27 ’25. On Jan 23 ’25, another insider, SHARP PHILLIP A, who serves as the Director of the company, sold 11,250 shares for $275.00 each. As a result, the insider received 3,093,750 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALNY now has a Market Capitalization of 35748372480 and an Enterprise Value of 35285438464. For the stock, the TTM Price-to-Sale (P/S) ratio is 17.07 while its Price-to-Book (P/B) ratio in mrq is 1103.70. Its current Enterprise Value per Revenue stands at 16.844 whereas that against EBITDA is -267.019.
Stock Price History:
The Beta on a monthly basis for ALNY is 0.35, which has changed by 0.5832081 over the last 52 weeks, in comparison to a change of 0.21794415 over the same period for the S&P500. Over the past 52 weeks, ALNY has reached a high of $304.39, while it has fallen to a 52-week low of $141.98. The 50-Day Moving Average of the stock is 11.04%, while the 200-Day Moving Average is calculated to be 18.52%.
Shares Statistics:
According to the various share statistics, ALNY traded on average about 747.55K shares per day over the past 3-months and 718800 shares per day over the past 10 days. A total of 128.84M shares are outstanding, with a floating share count of 127.94M. Insiders hold about 0.80% of the company’s shares, while institutions hold 96.82% stake in the company. Shares short for ALNY as of 1736899200 were 3151055 with a Short Ratio of 4.22, compared to 1734048000 on 3489237. Therefore, it implies a Short% of Shares Outstanding of 3151055 and a Short% of Float of 2.8099999.
